Piper Jaffray Resumes Coverage on DURECT (DRRX) with a Buy

December 16, 2008 8:58 AM EST Send to a Friend
Piper Jaffray & Co. resumes coverage on DURECT Corporation (Nasdaq: DRRX) with a Buy. Price target $6.

Piper ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login